Plasma levels of cyclic nucleotides are elevated in atopic eczema.
Plasma cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) taken at distinct times of the day were measured in 45 inpatients with generalized atopic eczema (AE). The results were compared with 34 healthy controls. Female patients not taking oral contraceptives (OC) and male patients revealed significantly higher median levels of cAMP in comparison with the controls (p less than 0.002 for males; p less than 0.001 for females). No significant cAMP differences were found between patients of either sex and female controls taking OC. The median cGMP plasma levels did not differ between patients and controls. Both cyclic nucleotides are discussed under the aspect of cAMP as a second messenger of various hormones, reflecting and integrating different responses of the body to AE as a distressing systemic skin disorder.
Schwarz
W
W
Department of Dermatology, University of Erlangen-Nürnberg, Federal Republic of Germany.
Bock
G
G
Hornstein
O P
OP
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D002940:Circadian Rhythm; D000242:Cyclic AMP / Q000097:blood*; D006152:Cyclic GMP / Q000097:blood*; D003876:Dermatitis, Atopic / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D000242:Cyclic AMP; D006152:Cyclic GMP